Event: Poster presentation: New Exploratory Alzheimer’s Drug ANAVEX 2-73: Dose Dependent Clinical Cognitive Improvement Observed in Mini Mental State Examination (MMSE) and Other Cognitive Markers in a Phase 2a Study in Mild-to-Moderate Alzheimer’s Patients

Date/Time:Sunday, July 24, 2016; 9:30 a.m. to 10:30 a.m. EDT

Location: Hall D/E, Metro Toronto Convention Centre, Toronto, ON